<DOC>
	<DOCNO>NCT01063764</DOCNO>
	<brief_summary>Objective First Period : To evaluate efficacy Levetiracetam dry syrup dos maximum 60 mg/kg/day 3000 mg/day use adjunctive therapy Japanese pediatric patient ( 4 16 year ) uncontrolled partial seizure despite treatment 1 2 anti-epileptic drug ( ) .</brief_summary>
	<brief_title>An Open Label Study Levetiracetam Japanese Pediatric Patients With Partial Seizures</brief_title>
	<detailed_description>Objectives Second Period : To provide Levetiracetam treatment subject judge investigator benefit long-term treatment willing continuously receive drug . To continuously evaluate safety Levetiracetam long-term administration dose range 20 mg/kg/day 1000 mg/day 60 mg/kg/day 3000 mg/day subject complete First Period study .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>The patient partial Epilepsy diagnosis must confirm last 6 month The patient must stable 1 2 antiepileptic drug ( ) treatment 4 week prior Baseline must least 8 partial seizure 8week prospective Baseline Period Patient age 4 16 year , body weight 11 82 kg The patient treatable seizure etiology The patient Epilepsy secondary progressive cerebral disease progressively neurodegenerative disease , include Rasmussen LandauKleffner diseases The patient history status Epilepticus 3 month prior Visit 1 The patient past present history pseudo seizures The patient current diagnosis LennoxGastaut syndrome</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Keppra</keyword>
	<keyword>Levetiracetam</keyword>
	<keyword>Children</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Partial Seizures</keyword>
</DOC>